Announce Date | 08/20/2025 |
EPS Normalized Actual | $0.09 (Miss by $-0.00725) |
EPS GAAP Actual | $0.09 (Miss by $-0.00725) |
Revenue Actual | $3.411B |
Revenue Surprise | Beat by $3411M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.62395 |
EPS GAAP Estimate | $0.62395 |
Revenue Estimate | $4.100385395B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2028 | 8.17507 | 10.9 | 7.94164 | 8.44801 | 4 |
Jun 2027 | 6.90415 | 12.91 | 6.70701 | 7.13466 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -1.51 | -1.51 | 3.411B | -13.08% | 3411M |
FQ1 2025 (Mar 2025) | 0.44 | -0.84887 | 3.55B | -42.17% | -613.07M |
FQ4 2024 (Dec 2024) | -1.64 | -1.64 | 4.004B | -6.87% | 4004M |
FQ3 2024 (Sep 2024) | -0.43 | -0.43 | 3.361B | -36.51% | 3361M |
FQ2 2024 (Jun 2024) | -0.79 | -0.79 | 3.857B | -23.72% | 3857M |
FQ1 2024 (Mar 2024) | 0.92 | 0.92 | 5.047B | 25.68% | 5047M |
FQ4 2023 (Dec 2023) | 0.87 | 0.87 | 4.279B | -7.97% | 4279M |
FQ3 2023 (Sep 2023) | 0.0865 | 0.0865 | 4.588B | 14.34% | 4588M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.62395
Consensus Revenue Estimates
4.100385395B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 1.21047 | -- | 1.1797 | 1.23427 | 6 |
FQ4 2027 (Dec 2027) | 1.35009 | -- | 1.31577 | 1.37664 | 5 |
FQ3 2027 (Sep 2027) | 0.39351 | -- | 0.38351 | 0.40125 | 5 |
FQ1 2027 (Mar 2027) | 1.47 | -- | 1.47 | 1.47 | 7 |
FQ4 2026 (Dec 2026) | 1.48 | -- | 1.48 | 1.48 | 7 |
FQ3 2026 (Jul 2026) | 1.05502 | -- | 1.02159 | 1.11045 | 5 |
FQ1 2026 (Mar 2026) | 1.34457 | 67.28 | 1.29928 | 1.40214 | 9 |
FQ4 2025 (Oct 2025) | 0.99381 | 265.02 | 0.96232 | 1.04603 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 4.15B | -- | 4.07B | 4.22B | 5 |
FQ4 2027 (Dec 2027) | 4.54B | -- | 4.45B | 4.61B | 6 |
FQ3 2027 (Sep 2027) | 3.71B | -- | 3.64B | 3.77B | 6 |
FQ1 2027 (Mar 2027) | 4.56B | -- | 4.56B | 4.56B | 9 |
FQ4 2026 (Dec 2026) | 4.74B | -- | 4.74B | 4.74B | 9 |
FQ3 2026 (Jul 2026) | 4.42B | -- | 4.32B | 4.6B | 5 |
FQ1 2026 (Mar 2026) | 4.47B | 20.59 | 4.35B | 4.62B | 7 |
FQ4 2025 (Oct 2025) | 4.1B | 2.35 | 4B | 4.27B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -1.51 | -1.51 | 100% | |
FQ1 2025 (Mar 2025) | 1.28887 | 0.44 | -0.84887 | -192.93% |
FQ4 2024 (Dec 2024) | -1.64 | -1.64 | 100% | |
FQ3 2024 (Sep 2024) | -0.43 | -0.43 | 100% | |
FQ2 2024 (Jun 2024) | -0.79 | -0.79 | 100% | |
FQ1 2024 (Mar 2024) | 0.92 | 0.92 | 100% | |
FQ4 2023 (Dec 2023) | 0.87 | 0.87 | 100% | |
FQ3 2023 (Sep 2023) | 0.0865 | 0.0865 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $3.41B | $3411M | 100% |
FQ1 2025 (Mar 2025) | $4.16B | $3.55B | $-613.07M | -17.27% |
FQ4 2024 (Dec 2024) | $0B | $4B | $4004M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.36B | $3361M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.86B | $3857M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.05B | $5047M | 100% |
FQ4 2023 (Dec 2023) | $0B | $4.28B | $4279M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.59B | $4588M | 100% |